NCT07831681 The Impact of a Collaborative Therapeutic Game in the Management of Psychiatric Symptoms in Adolescents
| NCT ID | NCT07831681 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Center Guillaume Régnier |
| Condition | Teenager |
| Study Type | OBSERVATIONAL |
| Enrollment | 16 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 16 participants in total. It began in 2025-03-01 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
When faced with psychiatric symptoms-which are characterized, in particular, by a unique perception of one's environment, the intentions of others, or events- the investigators now know that early intervention is crucial. For adults, there is a therapeutic tool in the form of a collaborative game that helps patients better understand and cope with these symptoms. A version of this game adapted for adolescents has been created: "L'océan des possibles" in French which is translated in English in "The Ocean of possibilities" (that term will be used throughout the rest of the protocol). It is used as part of a support group at the Guillaume Regnier Hospital Center. The objective of the study is to examine in detail the impact of this game on psychiatric symptoms and patients' perceptions of those symptoms by comparing it with the impact of other types of treatment. To this end, during follow-up interviews regarding the proposed treatments, the standard assessment interview will be supplemented with additional questionnaires. The investigators plan to include 16 adolescents, aged 12 to 17, with 8 in the treatment group using the game and 8 receiving another type of treatment. The patients will receive care tailored to their needs from the investigators' healthcare teams. The patients participation in this study will last 1 year and will involve: * an enrollment visit * 2 scheduled follow-up visits (3 months and 6 months after the end of treatment) These visits will take place during the routine follow-up appointments held just before the start of treatment, and 3 months and 6 months after the end of treatment. Additional assessments, consisting of questionnaires and standardized scales, will be conducted to analyze The patients' symptoms, their awareness of their difficulties ("insight"), their executive functioning, and their social and interpersonal skills in greater detail. The pre-treatment assessment should take about 1 hour and 20 minutes, and the following two assessments about 1 hour and 45 minutes each. The duration of these assessments may be adjusted, with the option to complete part of the questionnaires on their own after the interview.
Eligibility Criteria
Inclusion Criteria: * Teenager from 12 to 17 receiving outpatient care in childrens' and teenagers' psychiatrie unit * Patients with psychotic symptoms (delusions, hallucinations) and thought rigidity assessed using scales (SIPS, K-SADS, SDQ) * A patient enrolled in or eligible for a social security program * Patients and parents who have received informed information about the study and have signed a consent form to participate in the study Exclusion Criteria: \- Patients with a previous diagnosis of Autism Spectrum Disorder
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07831681 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Teenager. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07831681 currently recruiting?
Yes, NCT07831681 is actively recruiting participants. Contact the research team at v.chauvel@ch-guillaumeregnier.fr for enrollment information.
Where is the NCT07831681 trial being conducted?
This trial is being conducted at Rennes, France.
Who is sponsoring the NCT07831681 clinical trial?
NCT07831681 is sponsored by Hospital Center Guillaume Régnier. The trial plans to enroll 16 participants.